RAND Research Topic: Alzheimer's Disease and Dementias2024-03-23T01:33:21ZCopyright (c) 2024, The RAND CorporationRAND Corporationhttps://www.rand.org/topics/alzheimers-disease-and-dementias.htmlPreparing for the Potential Rollout of New Alzheimer's Drugs: Towards a Policy, Research, and Innovation AgendaRAND Corporationhttps://www.rand.org/pubs/commentary/2024/01/preparing-for-the-potential-roll-out-of-new-alzheimers.html2024-01-30T16:30:00Z2024-01-30T16:30:00ZSeveral promising new drugs appear to slow cognitive decline in individuals with early-stage Alzheimer's disease. A number of challenges need to be addressed to ensure their successful rollout, but there are also opportunities for health innovation.Modeling Early Detection and Geographic Variation in Health System Capacity for Alzheimer’s Disease–Modifying TherapiesJodi L. Liu; Lawrence Baker; Annie Chen; Jessie Wang; Federico Girosihttps://www.rand.org/pubs/research_reports/RRA2643-1.html2024-01-30T00:01:00Z2024-01-30T00:01:00ZThe authors modeled how patient uptake and health care system capacity will affect the delivery of Alzheimer’s disease–modifying therapies. They expand on prior work by examining the role of primary care and U.S. geographic variation in capacity.